• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Medical Device Problem Code Premature Activation (1484)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/28/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the stent inadvertently deployed.This 7x40, 130 cm eluvia drug-eluting vascular stent system was selected for use in a procedure for peripheral artery disease.Upon opening the device packaging, the stent was partially deployed.It appeared that the thumbwheel protector and rear blue pull tab were intact, and the distal portion of the stent was exposed and partially flared out.The procedure was completed using a new stent.There were no patient complications.
 
Additional Manufacturer Narrative
Device eval by manufacturer: upon receipt at our post market quality assurance laboratory, this eluvia drug-eluting vascular stent system was inspected for damage.Visual examination revealed that the stent was partially deployed 7mm from the distal end of the middle sheath.The outer sheath was kinked at the nosecone.Microscopic examination revealed no additional damages.The pull rack and thumbwheel lock were still in the manufactured position.Inspection of the remainder of the device revealed no other damage or irregularities.Product analysis found damage that could have contributed to the inadvertent deployment.
 
Event or Problem Description
It was reported that the stent inadvertently deployed.This 7x40, 130 cm eluvia drug-eluting vascular stent system was selected for use in a procedure for peripheral artery disease.Upon opening the device packaging, the stent was partially deployed.It appeared that the thumbwheel protector and rear blue pull tab were intact, and the distal portion of the stent was exposed and partially flared out.The procedure was completed using a new stent.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17442213
Report Number2124215-2023-40982
Device Sequence Number2735893
Product Code NIU
UDI-Device Identifier08714729876694
UDI-Public08714729876694
Combination Product (Y/N)Y
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P180011
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/10/2024
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0030579263
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 07/31/2023
Supplement Date Received by Manufacturer09/07/2023
Initial Report FDA Received Date08/02/2023
Supplement Report FDA Received Date09/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/11/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-